AF
GLSI icon

Advisornet Financial’s Greenwich LifeSciences GLSI Stock Holding History

Advisornet Financial’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50
Closed -$526 – 2222
2023
Q4 		$526 Hold
50
– – ﹤0.01% 2086
2023
Q3 		$442 Hold
50
– – ﹤0.01% 2011
2023
Q2 		$482 Hold
50
– – ﹤0.01% 2060
2023
Q1 		$690 Buy
+50
New +$793 ﹤0.01% 1990

Other funds holding GLSI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Advisornet Financial's GLSI Position: Q1 2024 in Review

Advisornet Financial sold out of Greenwich LifeSciences (GLSI) in Q1 2024, closing a stake of 50 shares — an estimated $526 sold.

Advisornet Financial first reported a position in GLSI in Q1 2023 and held it in 4 quarters. The position peaked at $690 in Q1 2023. 31 funds tracked by Wall St. Rank hold GLSI as of Q1 2024.

  • Advisornet Financial reported no remaining Greenwich LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Advisornet Financial sold 50 Greenwich LifeSciences shares in Q1 2024, an estimated $526.
  • Advisornet Financial first reported a position in Greenwich LifeSciences in Q1 2023 and held it in 4 quarters.
  • Advisornet Financial's Greenwich LifeSciences position peaked at $690 in Q1 2023.
  • 31 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2024.

Based on Advisornet Financial's 13F filing for Q1 2024, filed 12 Apr 2024.